Response to direct acting antivirals in vertically HIV/HCV co-infected youths

被引：0
|
作者：
Carrasco, I. [1 ]
Sainz, T. [2 ]
Frick, M. A. [3 ]
Jimenez de Ory, S. [1 ]
Montero, M. [4 ]
Gavilan, C. [5 ]
Falcon, M. D. [6 ]
Couceiro, J. A. [7 ]
Bernardino, J. I. [2 ]
Rubio, R. [8 ]
Bisbal, O. [8 ]
Guerrero, C. [9 ]
Aldamiz-Echevarria, M. T. [1 ]
Miralles, P. [1 ]
Berenguer, J. [1 ]
Navarro, M. L. [1 ]
机构：
[1] IiSGM Gregorio Maranon Univ Hosp, Madrid, Spain
[2] La Paz Univ Hosp, Madrid, Spain
[3] Vall dHebron Univ Hosp, Barcelona, Spain
[4] La Fe Univ & Polytech Hosp, Valencia, Spain
[5] San Juan de Alicante Hosp, Alicante, Spain
[6] Virgen del Rocio Univ Hosp, Seville, Spain
[7] Pontevedra Hosp Complex, Pontevedra, Spain
[8] 12 Octubre Hosp, Madrid, Spain
[9] Miguel Servet Univ Hosp, Madrid, Spain
来源：
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY | 2019年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
WEAB0205
引用
收藏
页码：48 / 48
页数：1
相关论文
共 50 条
  • [31] Initiating HCV treatment with direct acting agents in opioid agonist treatment: When to start for people co-infected with HIV?
    Panagiotoglou, Dimitra
    Krebs, Emanuel
    Min, Jeong Eun
    Olding, Michelle
    Ahamad, Keith
    Ti, Lianping
    Montaner, Julio S. G.
    Nosyk, Bohdan
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2017, 47 : 169 - 176
  • [32] Impact of Directly Acting Antivirals (DAAs) Treatment on Rates of Hepatocellular Carcinoma (HCC) in Hepatitis C Virus (HCV) and HIV Co-infected Patients
    Bari, Shahla
    Chan, Austin
    Olanipekun, Titilope
    Chawla, Saurabh
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S493 - S494
  • [33] Prevalence of risk factors for HCV transmission in HIV infected and HIV/HCV co-infected patients
    Bollepalli, S
    Mahthieson, K
    Post, J
    Hillier, A
    Nadir, A
    HEPATOLOGY, 2005, 42 (04) : 423A - 423A
  • [34] Peripheral blood HIV-1 DNA dynamics in antiretroviral-treated HIV/HCV co-infected patients receiving directly-acting antivirals
    Rozera, Gabriella
    Fabbri, Gabriele
    Lorenzini, Patrizia
    Mastrorosa, Ilaria
    Timelli, Laura
    Zaccarelli, Mauro
    Amendola, Alessandra
    Vergori, Alessandra
    Plazzi, Maria Maddalena
    Cicalini, Stefania
    Antinori, Andrea
    Capobianchi, Maria Rosaria
    Abbate, Isabella
    Ammassari, Adriana
    PLOS ONE, 2017, 12 (10):
  • [35] Direct-Acting Antivirals in the Treatment of Hepatitis C Virus (HCV)/Human Immunodeficiency Virus (HIV) Co-infected Patients: Real-Life Experience From Nepal
    Sudhamshu, K. C.
    Karki, Niyanta
    Sharma, Dilip
    Khadka, Sandip
    Tiwari, Pratap S.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (06)
  • [36] CD4 cell count before chronic hepatitis C (HCV) treatment with direct-acting antivirals (DAAs) and at the end of follow-up in HCV/HIV co-infected patients
    Mendez, Josefina
    Soeiro, Cristina
    Marques, Marta
    Goncalves, Celina
    Tavares, Ana Paula
    Horta, Ana
    Vasconcelos, Olga
    Seabra, Joao
    Abreu, Miguel
    Sarmento e Castro, Rui
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2016, 19
  • [37] Acute fulminant hepatitis B during hepatitis C virus therapy with direct-acting antivirals in a patient co-infected with HIV
    Paniagua-Garcia, Maria
    Lopez-Hernandez, Inmaculada
    Fernandez-Cuenca, Felipe
    Jose Rios-Villegas, Maria
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2017, 35 (10): : 681 - 682
  • [38] REGRESSION OF LIVER FIBROSIS AFTER SVR FROM DIRECT-ACTING ANTIVIRALS (DAAS) IN HEPATITIS C HIV CO-INFECTED PATIENTS
    Hamed, Almutasem
    Brown, Melinda S.
    Szabela, Maria
    Slim, Jihad
    GASTROENTEROLOGY, 2018, 154 (06) : S1203 - S1204
  • [39] Changes of body immunity and inflammatory response in HIV/HCV co-infected patients
    Dong, Yuhong
    Zhi, Xiaoli
    Lei, Guo
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2019, 17 (01) : 403 - 407
  • [40] Survival in HCV/HIV co-infected patients.
    Hassanein, TI
    Aronson, N
    Oliver, DL
    Barber, E
    Hilsabeck, RC
    Chatfield, E
    Stewart, M
    Mathews, C
    HEPATOLOGY, 2001, 34 (04) : 232A - 232A
12345